Anixa Biosciences Inc — Director's Dealing 2017

Oct 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-09-22

Reporting Person: WILLIAMS RICHARD H (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-22	Common Stock	A	50000	—	Acquired	100000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-22	Employee Stock Options (right to Buy)	$2.27	A	50000	Acquired	2027-09-22	Common Stock (50000)	Direct
2017-09-22	Employee Stock Options (right to Buy)	$2.27	A	50000	Acquired	2027-09-22	Common Stock (50000)	Direct

Footnotes

F1: Stock Award granted under the ITUS Corporation 2010 Share Incentive Plan (the "Plan").

F2: Right-To-Buy, pursuant to the Plan.

F3: The options vest and become exercisable in four (4) equal installments on each of December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018.